- DelphX Capital Markets (DPXCF, Financial) seeks to extend the exercise period of 5,430,250 share purchase warrants by one year.
- The warrants, originally issued in June 2023, are exercisable at $0.15 per common share.
- 93% of these warrants are held by related parties, but formal minority approval is not required.
DelphX Capital Markets Inc. (DPXCF) has announced its intention to seek approval from the TSX Venture Exchange to extend the exercise period of 5,430,250 share purchase warrants. The proposed extension will move the expiry date from June 29, 2025, to June 29, 2026. These warrants, issued as part of a private placement in June 2023, allow holders to purchase common shares at an exercise price of $0.15.
A significant portion of these warrants, approximately 5,055,250, is held by related parties, which constitutes a related party transaction under Multilateral Instrument 61-101. Despite this, DelphX is exempt from the formal valuation and minority approval requirements since the fair market value of the warrants is less than 25% of DelphX's market capitalization. All other terms and conditions of the warrants remain unchanged.
DelphX Capital Markets is a financial services firm focused on innovative structured products for the fixed income market. Through its advanced offerings, the company aims to provide enhanced security and attractive returns for investors and financial dealers.
